- Home
- ABM vs APLS Comparison
ABM vs APLS Comparison
Compare ABM & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABM | APLS |
|---|---|---|
| Founded | 1909 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ABM | APLS |
|---|---|---|
| Price | $37.49 | $17.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 21 |
| Target Price | ★ $47.80 | $31.65 |
| AVG Volume (30 Days) | 486.8K | ★ 1.8M |
| Earning Date | 03-10-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | 102.34 | ★ 112.50 |
| EPS | ★ 0.64 | 0.20 |
| Revenue | ★ $8,745,900,000.00 | $1,003,782,000.00 |
| Revenue This Year | $5.71 | N/A |
| Revenue Next Year | $1.99 | $17.97 |
| P/E Ratio | ★ $58.59 | $89.68 |
| Revenue Growth | 4.62 | ★ 28.46 |
| 52 Week Low | $37.43 | $16.10 |
| 52 Week High | $52.94 | $30.48 |
Technical Indicators
Market Signals| Indicator | ABM | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 21.28 | 27.58 |
| Support Level | N/A | $17.16 |
| Resistance Level | $46.93 | $20.42 |
| Average True Range (ATR) | 1.35 | 0.73 |
| MACD | -0.64 | -0.16 |
| Stochastic Oscillator | 0.93 | 12.94 |
Price Performance
Historical ComparisonAbout ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.